Cofactor AI, a company that helps hospitals appeal claims denials, announced it raised $4 million in a seed funding round led by Drive Capital. Cofactor AI’s platform, Cofactor Denial Suite, combines ...
SAN FRANCISCO--(BUSINESS WIRE)--Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major ...
CHICAGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Hospitals across the country are facing an ever-increasing onslaught of claims denials from insurance companies, with denials up 20.2% in 2023, according to ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Cofactor AI has created software that uses artificial ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a commercial-stage company bridging the precision medicine gap by decoding RNA, announced that experienced industry leader Chris Parker has been ...
SAN DIEGO, May 30, 2025--(BUSINESS WIRE)--Cofactor Genomics announced the latest validation results for OncoPrism ®, Cofactor’s breakthrough RNA-based diagnostic approach at the RNA Society’s 30th ...
As part of Y Combinator’s push into computational biology and bioinformatics, the early-stage firm is backing a team that used to work on the Human Genome Project and is now experimenting with RNA ...
Patent Represents Major Step Towards Bridging the Precision Medicine Gap Cofactor Genomics is bridging the precision medicine gap by building diagnostic tools to match the right patient to the right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results